Jayoung Jeong

Jayoung Jeong

Auto-generated profile, based on publicly available information

Jayoung Jeong

Division of Toxicological Research, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, 187, Osongsaengmyeong 2-ro, Cheongju 28159, Korea

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2013 in Particle and Fibre Toxicology
Verified
Journal Article
Open access
PDF file
WCWan-Seob Cho
Wan-Seob Cho
BKByeong-Cheol Kang
Byeong-Cheol Kang
JLJong Kwon Lee
Jong Kwon Lee
JJJayoung Jeong
Jayoung Jeong
JCJeong-Hwan Che
Jeong-Hwan Che
SSSeung Hyeok Seok
Seung Hyeok Seok
Background: The in vivo kinetics of nanoparticles is an essential to understand the hazard of nanoparticles. Here, the absorption, distribution, and excretion patterns of titanium dioxide (TiO2) and zinc oxide (ZnO) nanoparticles following oral administration were evaluated. Methods: Nanoparticles were orally administered to rats for 13 weeks (7 days/week). Samples of blood, tissues (liver, kidneys, spleen, and brain), urine, and feces were obtained at necropsy. The level of Ti or Zn in each sample was measured using inductively coupled plasma-mass spectrometry. Results: TiO2 nanoparticles had extremely low absorption, while ZnO nanoparticles had higher absorption and a clear dose-response curve. Tissue distribution data showed that TiO2 nanoparticles were not significantly increased in sampled organs, even in the group receiving the highest dose (1041.5 mg/kg body weight). In contrast, Zn concentrations in the liver and kidney were significantly increased compared with the vehicle control. ZnO nanoparticles in the spleen and brain were minimally increased. Ti concentrations were not significantly increased in the urine, while Zn levels were significantly increased in the urine, again with a clear dose-response curve. Very high concentrations of Ti were detected in the feces, while much less Zn was detected in the feces. Conclusions: Compared with TiO2 nanoparticles, ZnO nanoparticles demonstrated higher absorption and more extensive organ distribution when administered orally. The higher absorption of ZnO than TiO2 nanoparticles might be due to the higher dissolution rate in acidic gastric fluid, although more thorough studies are needed.

25 October 2013 in Particle and Fibre Toxicology
Verified
Journal Article
Open access
PDF file
WCWan-Seob Cho
Wan-Seob Cho
RDRodger Duffin
Rodger Duffin
Mark BradleyMark Bradley
Mark Bradley
Ian MegsonIan Megson
Ian Megson
WMWilliam MacNee
William MacNee
KDKen Donaldson
Ken Donaldson
Background: Hazard identification for risk assessment of nanoparticles (NPs) is mainly composed ofin vitrocell-based assays andin vivoanimal experimentation. The rapidly increasing number and functionalizations of NPs makesin vivotoxicity tests undesirable on both ethical and financial grounds, creating an urgent need for development ofin vitrocell-based assays that accurately predictin vivotoxicity and facilitate safe nanotechnology.Methods: In this study, we used 9 different NPs (CeO2, TiO2, carbon black, SiO2, NiO, Co3O4, Cr2O3, CuO, and ZnO). As anin vivotoxicity endpoint, the acute lung inflammogenicity in a rat instillation model was compared with thein vitrotoxicity endpoints comprising cytotoxicity, pro-inflammatory cytokine expression, or haemolytic potential. Forin vitroassays, 8 different cell-based assays were used including epithelial cells, monocytic/macrophage cells, human erythrocytes, and combined culture.Results: ZnO and CuO NPs acting via soluble toxic ions showed positive results in most of assays and were consistent with the lung inflammation data. When compared inin vitroassays at the same surface area dose (30 cm2/mL), NPs that were low solubility and therefore acting via surface reactivity had no convincing activity, except for CeO2NP. Cytotoxicity in differentiated peripheral blood mononuclear cells was the most accurate showing 89% accuracy and 11% false negativity in predicting acute lung inflammogenicity. However, the haemolysis assay showed 100% consistency with the lung inflammation if any dose, having statistical significance was considered positivity. Other cell-basedin vitroassays showed a poorer correlation within vivoinflammogenicity.Conclusions: Based on the toxicity mechanisms of NPs, two different approaches can be applied for prediction ofin vivolung inflammogenicity. Mostin vitroassays were good at detecting NPs that act via soluble ions (i.e., ZnO and CuO NP). However,in vitroassays were limited in detecting NPs acting via surface reactivity as their mechanism of toxicity, except for the haemolysis assay.

29 April 2016 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
JLJong Kwon Lee
Jong Kwon Lee
AJA Young Jeong
A Young Jeong
JBJiyeong Bae
Jiyeong Bae
JSJi Hyun Seok
Ji Hyun Seok
JYJun-Young Yang
Jun-Young Yang
WCWan-Seob Cho
Wan-Seob Cho

8 August 2020 in Toxics
Verified
Journal Article
Open access
PDF file
SHSo-Hye Hong
So-Hye Hong
SLSeung Hee Lee
Seung Hee Lee
JYJun-Young Yang
Jun-Young Yang
JLJin Hee Lee
Jin Hee Lee
KJKi Kyung Jung
Ki Kyung Jung
SHSo-Hye Hong
So-Hye Hong
The compound 6:2 chlorinated polyfluorinated ether sulfonate (F-53B), a replacement for perfluorooctanesulfonate (PFOS) in the electroplating industry, has been widely detected in numerous environmental matrices, human sera, and organisms. Due to regulations that limit PFOS use, F-53B use is expected to increase. Therefore, in this study, we performed a subchronic oral toxicity study of F-53B in Sprague Dawley (SD) rats. F-53B was administered orally once daily to male and female rats for 28 days at doses of 5, 20, and 100 mg/kg/day. There were no toxicologically significant changes in F-53B-treated rats, except in the thyroid gland. However, F-53B slightly reduced the serum concentrations of thyroid hormones, including triiodothyronine and thyroxine, compared with their concentrations in the vehicle group. F-53B also induced follicular hyperplasia and was associated with increased thyroid hormone biosynthesis-associated protein expression. These results demonstrate that F-53B is a strong regulator of thyroid hormones in SD rats as it disrupts thyroid function. Thus, caution should be exercised in the industrial application of F-53B as an alternative for PFOS.

28 October 2014 in Journal of Applied Toxicology
Verified
Journal Article
Closed access
PDF file
JLJong Kwon Lee
Jong Kwon Lee
TKTae Sung Kim
Tae Sung Kim
JBJi Young Bae
Ji Young Bae
AJA. Young Jung
A. Young Jung
SLSang Min Lee
Sang Min Lee
WCWan-Seob Cho
Wan-Seob Cho

19 July 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JYJun-Young Yang
Jun-Young Yang
JBJiyeong Bae
Jiyeong Bae
AJAyoung Jung
Ayoung Jung
SPSeonyeong Park
Seonyeong Park
SCSeungtae Chung
Seungtae Chung
WCWan-Seob Cho
Wan-Seob Cho
Zinc oxide nanoparticles (ZnO NPs) have many biomedical applications such as chemotherapy agents, vaccine adjuvants, and biosensors but its hemocompatibility is still poorly understood, especially in the event of direct contact of NPs with blood components. Here, we investigated the impact of size and surface functional groups on the platelet homeostasis. ZnO NPs were synthesized in two different sizes (20 and 100 nm) and with three different functional surface groups (pristine, citrate, and L-serine). ZnO NPs were incubated with plasma collected from healthy rats to evaluate the coagulation time, kinetics of thrombin generation, and profile of levels of coagulation factors in the supernatant and coronated onto the ZnO NPs. Measurements of plasma coagulation time showed that all types of ZnO NPs prolonged both active partial thromboplastin time and prothrombin time in a dose-dependent manner but there was no size- or surface functionalization-specific pattern. The kinetics data of thrombin generation showed that ZnO NPs reduced the thrombin generation potential with functionalization-specificity in the order of pristine > citrate > L-serine but there was no size-specificity. The profile of levels of coagulation factors in the supernatant and coronated onto the ZnO NPs after incubation of platelet-poor plasma with ZnO NPs showed that ZnO NPs reduced the levels of coagulation factors in the supernatant with functionalization-specificity. Interestingly, the pattern of coagulation factors in the supernatant was consistent with the levels of coagulation factors adsorbed onto the NPs, which might imply that ZnO NPs simply adsorb coagulation factors rather than stimulating these factors. The reduced levels of coagulation factors in the supernatant were consistent with the delayed coagulation time and reduced potential for thrombin generation, which imply that the adsorbed coagulation factors are not functional.